Products

Eurand Minitabs® Nifedipine (once daily)

A A A

Eurand's Nifedipine is a sustained-release calcium antagonist product indicated for prophylaxis of chronic and stable angina and treatment of hypertension.


Therapeutic Category Cardiovascular
Indication
  • Chronic and stable angina
  • Hypertension
Available Dosage Strength(s)
  • 30 mg once daily
  • 60 mg once daily
Product Description
  • Sustained release (once daily) formulation of nifedipine
Eurand Technology
Advantages
  • Combines the simplicity of tablet formulation with the sophistication of multiparticulate systems in a convenient once daily therapy
  • Protected by issued and pending U.S. and international patents

This information is provided solely for the purpose of the evaluation of business opportunities by potential collaboration partners. The information is based on currently existing data and marketing authorizations in a number of jurisdictions and should not be assumed to be approved by regulatory authorities in any individual country. Consumers should consult with their individual physician for product information and should not rely upon any information provided here.

For more information on this product, please contact us at partners@eurand.com.

Cardiovascular Products

More Information

For more information, contact Eurand at partners@eurand.com or +1-267-759-9340

contact Eurand +